Synhale has acquired telaglenastat, and is planning a Phase 2 clinical trial testing the therapy in patients with pulmonary ...

There are night owls and morning larks, writes columnist Colleen Steele, referring to people's sleep habits. So which bird are you?

A pivotal study testing Sensydia's noninvasive device, which may help diagnose pulmonary hypertension, enrolled its first ...

Cereno Scientific reported a successful meeting with the FDA on the design of a future clinical trial for its PAH therapy ...

PHA launched a certificate program for healthcare professionals, providing specialized training for PH diagnosis, treatment, ...

On May 5, more than 80 organizations around the world will join to raise awareness of pulmonary hypertension (PH), a serious but often under-recognized cardiovascular disease affecting more than 75 ...

The PAH Initiative is hosting a video event in May to provide information about the benefits of exercise for people with pulmonary arterial hypertension (PAH). “The Power of Movement: Cardiopulmonary ...

Heart failure related to pulmonary arterial hypertension (PAH) is becoming more common, with patients living fewer years in full health, a trend that’s predicted to continue, with more cases and ...

Pulmonary artery denervation (PADN), a procedure that targets overactive nerves involved in blood vessel constriction, significantly lessens high blood pressure in the lungs of people with pulmonary ...